Rankings
▼
Calendar
CRON
Cronos Group Inc.
$981M
Q1 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$8M
Gross Profit
-$6M
-76.8% margin
Operating Income
-$45M
-534.4% margin
Net Income
$76M
901.8% margin
EPS (Diluted)
$0.20
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$46M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$213M
Stockholders' Equity
$1.7B
Cash & Equivalents
$1.1B
Revenue Segments
Cannabis Extracts
$6M
66%
Cannabis Flower
$3M
33%
Product and Service, Other
$115,000
1%
Geographic Segments
CANADA
$6M
72%
UNITED STATES
$2M
26%
Other Countries
$165,000
2%
← FY 2020
All Quarters
Q2 2020 →
CRON Q1 2020 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena
